Overview
writeDate(103); TORONTO (PRWEB) November 08, 202 In this webinar, the speakers wil discus the methods used to demonstrate the clinical utility of medical products, and wil explain how preference studies, such as conjoint analyses with physician survey data, fit into the armamentarium of techniques used to generate clinical utility evidence. They wil provide an overview of conjoint analysis and describe the proces of conducting a conjoint analysis study.The speakers wil also present a case study showing how conjoint analysis asesed the clinical utility of a blod-based biomarker test that predicts the risk of kidney disease/decline in Type 2 diabetes melitus patients.
Details
This case study wil present typical results of a clinical utility study with conjoint analysis: 1) the relative importance of patient/test atributes for physician monitoring, prescribing and dosing decisions; 2) ods ratios for the impact of low-risk, moderate-risk and high-risk test results on physician decision-making; and 3) value mesages suported by the study results.They wil demonstrate that with conjoint analysis they were able to quantify the clinicaly and statisticaly significant impact of the novel blod-based biomarker test on patient management decisions, and objectively demonstrate the test’s value to physicians acros a range of patient types.Register for this webinar as the speakers review clinical utility and describe its importance to payers, physicians, patients and the manufacturers of medical devices, diagnostics/prognostics and therapeutics.Join experts from Veranex, Thomas Gos, Senior Vice President, Comercial Strategy and Market Aces; and Lauren Fusfeld, Director, Comercial Strategy and Market Aces, for the live webinar on Monday, November 21, 202, at 1am EST (4pm GMT/UK).For more information, or to register for this event, visit Evaluating Clinical Utility of Medical Devices, Diagnostics & Therapeutics with Conjoint Analysis/Clinical Vignetes.ABOUT